Huapont Life Sciences Co Ltd (002004) - Net Assets

Latest as of March 2026: CN¥17.33 Billion CNY ≈ $2.54 Billion USD

Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) has net assets worth CN¥17.33 Billion CNY (≈ $2.54 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥29.83 Billion ≈ $4.37 Billion USD) and total liabilities (CN¥12.49 Billion ≈ $1.83 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Huapont Life Sciences Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥17.33 Billion
% of Total Assets	58.11%
Annual Growth Rate	24.55%
5-Year Change	7.3%
10-Year Change	58.62%
Growth Volatility	44.4

Huapont Life Sciences Co Ltd - Net Assets Trend (2001–2025)

This chart illustrates how Huapont Life Sciences Co Ltd's net assets have evolved over time, based on quarterly financial data. See Huapont Life Sciences Co Ltd (002004) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Huapont Life Sciences Co Ltd (2001–2025)

The table below shows the annual net assets of Huapont Life Sciences Co Ltd from 2001 to 2025. For live valuation and market cap data, see 002004 market cap overview.

Year	Net Assets	Change
2025-12-31	CN¥16.98 Billion ≈ $2.48 Billion	+9.73%
2024-12-31	CN¥15.47 Billion ≈ $2.26 Billion	-6.70%
2023-12-31	CN¥16.58 Billion ≈ $2.43 Billion	+0.21%
2022-12-31	CN¥16.55 Billion ≈ $2.42 Billion	+4.59%
2021-12-31	CN¥15.82 Billion ≈ $2.32 Billion	+11.93%
2020-12-31	CN¥14.14 Billion ≈ $2.07 Billion	+6.74%
2019-12-31	CN¥13.24 Billion ≈ $1.94 Billion	+3.88%
2018-12-31	CN¥12.75 Billion ≈ $1.87 Billion	-4.12%
2017-12-31	CN¥13.30 Billion ≈ $1.95 Billion	+24.22%
2016-12-31	CN¥10.70 Billion ≈ $1.57 Billion	+2.82%
2015-12-31	CN¥10.41 Billion ≈ $1.52 Billion	+81.62%
2014-12-31	CN¥5.73 Billion ≈ $838.76 Million	+42.86%
2013-12-31	CN¥4.01 Billion ≈ $587.13 Million	+35.69%
2012-12-31	CN¥2.96 Billion ≈ $432.69 Million	+14.35%
2011-12-31	CN¥2.59 Billion ≈ $378.40 Million	+149.66%
2010-12-31	CN¥1.04 Billion ≈ $151.57 Million	+15.43%
2009-12-31	CN¥897.32 Million ≈ $131.31 Million	+10.23%
2008-12-31	CN¥814.07 Million ≈ $119.12 Million	+11.38%
2007-12-31	CN¥730.86 Million ≈ $106.95 Million	+39.77%
2006-12-31	CN¥522.90 Million ≈ $76.52 Million	+18.66%
2005-12-31	CN¥440.68 Million ≈ $64.49 Million	+9.72%
2004-12-31	CN¥401.64 Million ≈ $58.77 Million	+175.58%
2003-12-31	CN¥145.74 Million ≈ $21.33 Million	+42.64%
2002-12-31	CN¥102.18 Million ≈ $14.95 Million	+16.80%
2001-12-31	CN¥87.48 Million ≈ $12.80 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Huapont Life Sciences Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 9847.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥1.82 Billion	17.77%
Other Components	CN¥8.40 Billion	82.23%
Total Equity	CN¥10.22 Billion	100.00%

Huapont Life Sciences Co Ltd Competitors by Market Cap

The table below lists competitors of Huapont Life Sciences Co Ltd ranked by their market capitalization.

Company	Market Cap
Sun Art Retail Group Limited F:SRI	$1.19 Billion
Refrigeration Electrical Engineering Corp VN:REE	$1.20 Billion
SK Reit Co Ltd KO:395400	$1.20 Billion
FuelCell Energy Inc NASDAQ:FCEL	$1.20 Billion
Jiajia Food Group Co Ltd SHE:002650	$1.19 Billion
Hangjin Technology Co Ltd SHE:000818	$1.19 Billion
Shanghai Hajime Advanced Material Technology Co. Ltd. SHE:301000	$1.19 Billion
Adtran Networks SE F:ADV	$1.19 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Huapont Life Sciences Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 9,337,058,000 to 10,219,770,870, a change of 882,712,870 (9.5%).
Net income of 713,188,344 contributed positively to equity growth.
Dividend payments of 668,497,085 reduced retained earnings.
Other comprehensive income decreased equity by 1,009,823,000.
Other factors increased equity by 1,847,844,610.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥713.19 Million	+6.98%
Dividends Paid	CN¥668.50 Million	-6.54%
Other Comprehensive Income	CN¥-1.01 Billion	-9.88%
Other Changes	CN¥1.85 Billion	+18.08%
Total Change	CN¥-	9.45%

Book Value vs Market Value Analysis

This analysis compares Huapont Life Sciences Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.80x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 46.74x to 0.80x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2001-12-31	CN¥0.09	CN¥4.12	x
2002-12-31	CN¥0.10	CN¥4.12	x
2003-12-31	CN¥0.15	CN¥4.12	x
2004-12-31	CN¥0.38	CN¥4.12	x
2005-12-31	CN¥0.43	CN¥4.12	x
2006-12-31	CN¥0.46	CN¥4.12	x
2007-12-31	CN¥0.67	CN¥4.12	x
2008-12-31	CN¥0.76	CN¥4.12	x
2009-12-31	CN¥0.85	CN¥4.12	x
2010-12-31	CN¥0.99	CN¥4.12	x
2011-12-31	CN¥2.41	CN¥4.12	x
2012-12-31	CN¥2.14	CN¥4.12	x
2013-12-31	CN¥2.66	CN¥4.12	x
2014-12-31	CN¥3.51	CN¥4.12	x
2015-12-31	CN¥5.09	CN¥4.12	x
2016-12-31	CN¥4.76	CN¥4.12	x
2017-12-31	CN¥4.69	CN¥4.12	x
2018-12-31	CN¥4.47	CN¥4.12	x
2019-12-31	CN¥4.67	CN¥4.12	x
2020-12-31	CN¥4.88	CN¥4.12	x
2021-12-31	CN¥5.11	CN¥4.12	x
2022-12-31	CN¥5.15	CN¥4.12	x
2023-12-31	CN¥5.10	CN¥4.12	x
2024-12-31	CN¥4.73	CN¥4.12	x
2025-12-31	CN¥5.16	CN¥4.12	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Huapont Life Sciences Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.98%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 6.19%
• Asset Turnover: 0.40x
• Equity Multiplier: 2.84x
Recent ROE (6.98%) is below the historical average (12.24%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2001	35.56%	17.87%	1.30x	1.52x	CN¥22.36 Million
2002	37.05%	18.63%	0.97x	2.06x	CN¥27.23 Million
2003	27.61%	16.60%	1.07x	1.56x	CN¥25.46 Million
2004	12.59%	17.48%	0.57x	1.27x	CN¥9.81 Million
2005	12.18%	19.20%	0.57x	1.11x	CN¥9.41 Million
2006	14.23%	22.28%	0.38x	1.70x	CN¥19.08 Million
2007	30.83%	41.93%	0.45x	1.63x	CN¥139.49 Million
2008	11.79%	15.70%	0.50x	1.51x	CN¥13.51 Million
2009	15.24%	23.45%	0.48x	1.36x	CN¥43.89 Million
2010	13.54%	24.40%	0.40x	1.39x	CN¥34.49 Million
2011	12.76%	48.54%	0.15x	1.75x	CN¥65.97 Million
2012	12.39%	8.57%	0.65x	2.21x	CN¥64.12 Million
2013	7.97%	6.78%	0.58x	2.01x	CN¥-77.04 Million
2014	7.70%	8.82%	0.36x	2.43x	CN¥-128.39 Million
2015	6.69%	10.31%	0.31x	2.07x	CN¥-315.69 Million
2016	5.88%	7.99%	0.29x	2.51x	CN¥-397.66 Million
2017	5.33%	5.51%	0.32x	3.06x	CN¥-443.51 Million
2018	5.59%	4.79%	0.40x	2.93x	CN¥-400.05 Million
2019	6.64%	6.15%	0.38x	2.85x	CN¥-313.87 Million
2020	6.77%	5.99%	0.39x	2.93x	CN¥-311.22 Million
2021	6.61%	5.37%	0.41x	2.97x	CN¥-343.13 Million
2022	4.25%	3.28%	0.44x	2.95x	CN¥-585.71 Million
2023	2.99%	2.61%	0.38x	3.04x	CN¥-708.40 Million
2024	-3.20%	-2.56%	0.40x	3.15x	CN¥-1.23 Billion
2025	6.98%	6.19%	0.40x	2.84x	CN¥-308.79 Million

Industry Comparison

This section compares Huapont Life Sciences Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.

Industry Context

Industry: Agricultural Inputs
Average net assets among peers: $3,810,968,802
Average return on equity (ROE) among peers: 7.30%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Huapont Life Sciences Co Ltd (002004)	CN¥17.33 Billion	35.56%	0.72x	$1.19 Billion
Hubei Yihua Chemical Industry Co Ltd (000422)	$492.29 Million	7.61%	0.82x	$2.09 Billion
Nanjing Red Sun Co Ltd (000525)	$3.98 Billion	4.57%	1.08x	$831.95 Million
ADAMA Ltd (000553)	$21.92 Billion	-7.32%	1.53x	$1.84 Billion
Grand Industrial Holding Co Ltd (000626)	$3.10 Billion	7.17%	1.46x	$517.47 Million
Sichuan Meifeng Chemical Industry Co Ltd (000731)	$3.04 Billion	5.61%	0.59x	$440.10 Million
Qinghai Salt Lake Industry Co.Ltd (000792)	$634.84 Million	10.65%	0.39x	$23.04 Billion
Asia Potash International Investment Guangzhou Co Ltd (000893)	$3.93 Billion	1.06%	0.07x	$5.53 Billion
Hubei Xinyangfeng Fertilizer Co Ltd (000902)	$452.01 Million	-10.57%	1.67x	$2.23 Billion
Sichuan Lutianhua Co Ltd (000912)	$218.75 Million	71.83%	0.84x	$782.42 Million
Guangxi Hechi Chemical Co Ltd (000953)	$341.44 Million	-17.59%	1.88x	$297.88 Million

About Huapont Life Sciences Co Ltd

SHE:002004 China Agricultural Inputs

Market Cap

$1.19 Billion

CN¥8.16 Billion CNY

Market Cap Rank

#8298 Global

#2018 in China

Share Price

CN¥4.12

Change (1 day)

-1.90%

52-Week Range

CN¥4.08 - CN¥5.88

All Time High

CN¥11.08